INTERNATIONAL PATENT: KOREA INSTITUTE OF ORIENTAL MEDICINE, 한국 한의학 연구원 FILES APPLICATION FOR "PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ANTICANCER DRUG-RESISTANT CANCER, CONTAINING TERIFLUNOMIDE AS ACTIVE INGREDIENT"

GENEVA, Nov. 4 -- KOREA INSTITUTE OF ORIENTAL MEDICINE (1672, Yuseong-daeroYuseong-guDaejeon 34054), 한국 한의학 연구원 (대전광역시유성구유성대로 1672) filed a patent application (PCT/KR2025/001171) for "PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ANTICANCER DRUG-RESISTANT CANCER, CONTAINING TERIFLUNOMIDE AS ACTIVE INGREDIENT" on Jan 21, 2025. With publication no. WO/2025/225833, the details related to the patent application was published on Oct 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property O...